Hertford, United Kingdom · Founded 2017 · Privately Held (backing)
Operator of a vaccine antigen design company intended to accelerate vaccine development to maximize the protection against existing and future viruses. DIOSynVax is based in Hertford, United Kingdom and was founded in 2017. Its last reported valuation was $31.6 million in Dec 2025. It has raised $9.8 million.
Last reported valuation
$31.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
—
Cap table — not yet on record
DIOSynVax's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of DIOSynVax with a free Private Market View account
·Watch DIOSynVax: the Monday email on marks, rounds and moves
